Current concepts in the management of superficial bladder cancer.
Soloway
M S
MS
Department of Urology, University of Tennessee, Memphis.
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003558:Cystoscopy; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D011379:Prognosis; D013852:Thiotepa / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*; D014613:Vaccines, Attenuated / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D008937:Mitomycins; D014613:Vaccines, Attenuated; D016685:Mitomycin; D004317:Doxorubicin; D013852:Thiotepa